Stratec SE (LTS:0RAR)
€ 31.5 -0.6 (-1.87%) Market Cap: 387.77 Mil Enterprise Value: 494.93 Mil PE Ratio: 38.43 PB Ratio: 1.70 GF Score: 83/100

Stratec SE at JPMorgan Healthcare Conference Transcript

Jan 11, 2024 / 03:30PM GMT
Release Date Price: €41.7 (-0.43%)
Unidentified Participant

Good morning, everyone, thank you for your time. Today we're here for STRATEC company presentation, led by the CEO of the company, Marcus Wolfinger. Marcus, over to you.

Marcus Wolfinger STRATEC SE;CEO

Yeah, good morning, everyone. And [Argon], thanks very much for the intro. Welcome to the presentation of STRATEC. This presentation actually includes forward looking statements.

Let me give you an overview of what we do, where we are, and where we intend to be. We are a leading supplier of automated solutions and consumables to the diagnostics industry and to the life science industry. Actually, we design and manufacture instrumentation and consumables on the basis of our own technology and intellectual property rights.

However, we do what we call design requirements by means of that together with our customers we work through an intensive process of trying to find out what the market actually needs and what kind of technologies are to be applied, leading to a specific product of the customer and the end user. The end

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot